BioCentury
ARTICLE | Company News

Advirna, RXi Pharmaceuticals deal

October 5, 2009 7:00 AM UTC

RXi acquired four of Advirna's RNAi delivery technologies for an undisclosed sum. RXi, which exercised an option to license the technologies in August, decided to purchase the technology based on prec...